During the World Advanced Therapies & Regenerative Medicine Congress 2018 in London, our CEO Dr. Hatim Hemeda spoke to Freya Leask (RegMedNet Editor) about the importance of animal component-free cell culture media and how they change the possibilities of regenerative medicine.
Our CEO Dr. Hatim Hemeda about animal component-free cell culture and market trends.
Animal component-free cell culture
PL BioScienceCorporate Communications
